Endocrinology

Host: Carol Wysham

Guest: Deepak Vashishth, PhD

Guest: Bowen Wang

Can we predict when a patient with COVID-19 requires hospitalization? To answer this question, Dr. Carol Wysham is joined by Dr. Deepak Vashishth and Mr. Bowen Wang from the Rensselaer Polytechnic Institute to share data from their study on the impact of glycemic levels and common medications on COVID-19 severity in patients with type 2 diabetes.

Host: Jacob Sands, MD

Guest: Yasmin Jayasinghe, FRANZCOG, PhD

Cancer treatment can impact fertility outcomes for individuals throughout the U.S. as well as around the globe, which is why the emerging field of oncofertility is here to help male and female patients navigate their fertility options before and after their cancer treatments. So what can we learn from oncofertility services and efforts from other countries around the world? Joining Dr. Jacob Sands to share her global viewpoints on the field of oncofertility is Dr. Yasmin Jayasinghe, Director of the Oncofertility Program at the Royal Children’s Hospital.

Host: Jacob Sands, MD

Guest: Yasmin Jayasinghe, FRANZCOG, PhD

Pediatric and adolescent oncofertility patients are cared for differently than adult patients. That’s why Dr. Yasmin Jayasinghe, Director of the Oncofertility Program at the Royal Children’s Hospital, is here to give us an overview of the available procedures for pediatric patients and the key considerations that go along with them.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

Host: Jacob Sands, MD

Guest: Suneeta Senapati, MD, MSCE

Guest: Mindy Christianson, MD

Patients undergoing treatments such as chemotherapy may be at significant risk of impairment or inability to have children later in life. This risk impacts both men and women equally, but fortunately, the field of oncofertility can help guide patients as they navigate their fertility options prior to cancer treatment. Here to share their insights on this emerging field with Dr. Jacob Sands are Dr. Mindy Christianson and Dr. Suneeta Senapati.

Host: Andrew Wilner, MD, FACP, FAAN

Guest: Emily Louise Johnson, MD

According to recent estimates, between 150,000 and 450,000 transgender patients have epilepsy. And as that number is only expected to grow, Assistant Professor of Neurology at Johns Hopkins School of Medicine Dr. Emily Johnson shares key considerations for treating transgender patients with epilepsy.

Host: John E. Anderson, MD

Guest: Michael Greenberg, MD

Dr. John Anderson joins Dr. Michael Greenberg, host of DermConsult, to discuss skin diseases that dermatologists should be aware of in patients with diabetes.

Host: Carol Wysham

Guest: Kristen Nadeau, MD, MS

Is there a link between type 2 diabetes and obesity? Dr. Carol Wysham joins Dr. Kristen Nadeau, a Professor of Pediatric Endocrinology at the University of Colorado School of Medicine, to review her research on type 2 diabetes and what it could mean for our patients.

Host: John E. Anderson, MD

Guest: Raghu Mirmira, MD,PhD

When treating type 1 diabetes, should we be focusing on disease prevention rather than reversal? Dr. John Anderson takes a look at prevention tactics for type 1 diabetes progression with Dr. Raghu Mirmira, a Professor of Medicine and the Director of the Translational Research Center at the University of Chicago.

Host: John Buse, MD, PhD

Guest: Anne Louise Peters, MD

SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.